Allianz Asset Management Gmb H Blueprint Medicines Corp Transaction History
Allianz Asset Management Gmb H
- $62.9 Billion
- Q1 2024
A detailed history of Allianz Asset Management Gmb H transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 8,700 shares of BPMC stock, worth $960,132. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,700
Previous 7,500
16.0%
Holding current value
$960,132
Previous $691,000
19.39%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding BPMC
# of Institutions
313Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$712 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$696 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$690 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$461 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$276 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.59B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...